Strategies for expanding hematopoietic stem cells (HSCs) could have significant utility for transplantation-based therapies. However, deleterious consequences of such manipulations remain unknown. Here we examined the impact of HSC selfrenewal divisions in-vitro and in-vivo on their subsequent regenerative and continuing ability to sustain blood cell production in the absence of telomerase.
Introduction
The existence of HSCs with a capacity for sustained self-renewal is essential for lifelong blood cell production. Expansion of the stem cell pool requires the stimulation of symmetric self-renewal divisions and is critical both during early development 1 and in later life 2, 3 , as well as after transplantation or following hematopoietic injury. When small numbers of HSCs are transplanted into myeloablated or pre-immune hosts, the increases in HSC numbers that follow may be even larger than those seen during development [4] [5] [6] . These findings document the high replicative potential of HSCs .
The self-renewal function of HSCs and their ability to re-establish hematopoiesis permanently in a myelosuppressed host is the basis of an increasing range of therapies for bone marrow (bm) failure, malignant and genetic disorders 10, 11 . Broader use (e.g., from cord blood sources) and improved safety (e.g., by accelerating recovery) of such transplant therapies would be greatly facilitated by the development of methods for achieving significant prior expansion of HSC numbers ex vivo [12] [13] [14] . However, it remains unclear, whether HSC self-renewal activity, provoked by either extrinsically or intrinsically induced mechanisms would at some point have deleterious consequences (e.g., by
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From inducing HSC senescence or an impairment of some critical aspect of HSC function). Studies reported to date indicate that despite detectable levels of telomerase expression 15 , the telomeres of leukocytes present in the blood of increasingly older people are increasingly shorter. This finding suggests that some HSC proliferation is constantly occurring in humans 16 . Similar results have been reported for hematopoietic cells produced in murine recipients of serially transplanted hematopoietic cells [17] [18] [19] .
The severe consequences of genetically determined telomerase deficiencies provide additional compelling evidence of the importance of telomerase in both humans and mice. Patients suffering from dyskeratosis congenita (DKC) or acquired aplastic anemia with loss of function mutations in telomerase complex genes 20,21 have short telomeres, frequently associated with a decreased proliferative capacity of their hematopoietic progenitors, bm failure and sometimes evidence of malignant progression due to genomic instability 22, 23 .
Similar to DKC patients, late generation telomerase-deficient mice (as mice possess significantly longer telomeres than humans and it takes up to 4 generations until the telomeres become critically short) generally suffer from genomic instability, defects in highly proliferative tissues 24 , including reduced replicative capacity 18 and repopulating ability 25 The results of the present studies confirm the importance of intact telomerase activity in maintaining the integrity of telomere length in HSCs that have . Tert -/-mice were maintained by heterozygous breeding at the BRC (UBC, Vancouver, Canada).
Transduction of mouse bone marrow cells
Generation of the MSCV-IRES-GFP (GFP) and the MSCV-NUP98-HOXA10hd-IRES-GFP (NA10hd) viral vectors was previously described 32 . Bm cells were obtained from mice injected 4 days previously with 150 mg/kg 5-fluorouracil (5-FU) (Mayne, Pharma, Montreal, QC, Canada) and transduced as previously described 14, 32 . Loosely adherent and nonadherent cells were recovered and Cells recovered at the end of the 6-days in culture and also from the bm aspirates obtained from mice 3 and 6 months post transplant were subjected to telomere length measurements (see following section). At 6 months posttransplant 1-2 primary recipients showing the highest level of donor-derived reconstitution were selected and donor-derived bm cells were isolated on a FACSDiVa (BD) for transplantation into secondary mice (3x10 6 cells/lethally irradiated secondary recipient). Pb was analysed for donor-derived wbc reconstitution 3 and 6 months post-transplantation.
Assessment of HSC frequencies
HSCs were detected and quantified using the limiting dilution competitive repopulating unit (CRU) assay, as previously described
32
. 
Colony forming cell (CFC) assays
Clonogenic hematopoietic progenitor cells were assayed by plating 1,500 cells per ml of methyl-cellulose culture medium (Methocult M3234, STEMCELL Technologies), containing 3 U/ml human erythropoietin, 10 ng/ml mouse interleukin (IL)-3, 10 ng/mL human IL-6, and 50 ng/ml mouse stem cell factor (SCF) (all recombinant from STEMCELL Technologies). After 7 days of culture, colonies were counted using standard scoring criteria, the cells pooled and the viable cells counted also. Equal cell numbers were replated in duplicates for a total of 3 times at weekly intervals to assess serial replating capacity. 
Results

Telomerase deficiency affects telomere homeostasis under conditions of prolonged self-renewal stimulation
In an initial series of experiments, primary recipients were transplanted with bm cells from either wild-type or Tert -/-mice which were not found to be different A recipient of GFP-transduced wild-type bm cells transplanted immediately after transduction was followed for 9 months with no detectable telomere attrition (data not shown). There was also no significant change in the telomere length in the progeny of NA10hd-transduced wild-type bm cells initially Interestingly, such a deficit in reconstituting ability of Tert -/-bm cells ( Figure 2F) was accompanied by skew to myeloid cells (data not shown) and a significant telomere loss ( Figure 2E ) only following NA10hd-enhanced HSC expansion in Figure 2D) . However, the phase of NA10hd-enhanced HSC expansion in vivo (Figure 2A, 2C ), appears to be independent of detectable telomere attrition . Thus, it cannot be excluded that HSC telomeres may stay long because of a telomerase-independent mechanism active in HSCs.
Telomeric DNA may also be generated through recombination events, a mechanism known as alternative lengthening of telomeres (ALT) 36 and shown to occur in embryonic stem cells and during early development , we showed that telomerase may function as a regulator of the HSC self-renewal process, as our results However, it is important to note the lack of deleterious effects seen on the greatly expanded wild-type HSC populations generated in the presence of intracellular NA10hd in relatively short term (6-day) cultures. This included lack of effects on both telomere homeostasis and overall genomic integrity. Although the current findings cannot be safely extrapolated to human HSCs, as inbred mice possess significantly longer telomeres than humans Conflict-of-interest disclosure: The authors declare no competing financial interests.
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